An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus

This study has been completed.
Sponsor:
Information provided by:
Biodel
ClinicalTrials.gov Identifier:
NCT00542724
First received: October 5, 2007
Last updated: January 21, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 21, 2010